Would you consider definitive radiation therapy in a patient with a newly diagnosed high risk prostate cancer and metastatic NSCLC on immunotherapy with no evidence of disease?
Would you consider radiation with concurrent immunotherapy? Would you limit RT fields? Would you use a lower dose per fraction given immunotherapy?